Mylan gets FDA OK for generic of Colazal

Mon Dec 31, 2007 8:23am EST

(Reuters) - Drug maker Mylan Inc MYL.N said its generic version of Salix Pharmaceuticals Ltd's (SLXP.O) Colazal capsules received final regulatory approval.

Mylan said Colazal capsules, which treats mild to moderate ulcerative colitis, had U.S. sales of about $130.9 million for the 12 months ending September 30.

Mylan said in a statement its product will be shipped immediately.

(Reporting by Shamik Paul in Bangalore)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.